
India vs Big Pharma: Compulsory licence for leukaemia drug sought
India vs Big Pharma: Compulsory licence for leukaemia drug sought
Big Pharma is an umbrella term used to describe major pharmaceutical companies across the world. The term was popularised by British journalist Jacky Law in a 2006 book in which he said that Big Pharma essentially controls the healthcare sectors in major countries to determine which problems should be publicised and researched.

India vs Big Pharma: Compulsory licence for leukaemia drug sought

Top health newsmakers of 2012

Latest Ebola News: Big pharma to blame for lack of Ebola vaccine?
Novartis AG loses patent battle, cancer drugs to be cheaper

Indian pharma to reach new heights but will it be able to maintain quality?

Global Big Pharma targeting Indian pharmaceutical industry?

A hard-hitting movie about the triumph of good over evil.
India vs Big Pharma: Roche's breast cancer drug Hereceptin loses patent

Ranbaxy's Indian facilities under scanner: Ghulam Nabi Azad

'Compulsory licence verdict a triumph for humanity'

Experts believe that this case will set a precedent for all future legal tangles between Big Pharma and the country as a marker of how cases pertaining to drug patents will be played out in the country.
Ranbaxy ordered to shell out 420,000 dollars as settlement to settle criminal complaints
Ranbaxy goes on mass retrenching spree: Set to fire 400 employees in the next few months
Supreme Court dismisses PIL against Ranbaxy Laboratories
Now consent for clinical trials to be recorded on camera
Ranbaxy to pay $500 mn to settle US fraud charges
What Monica Lewinsky and Indian generic drugs have in common – Bill Clinton loves them both
Now government hospitals in Maharashtra to use generic drugs
Novartis not optimistic about Supreme Court verdict
Leading lawyer calls India's pharma sector 'hip and hapenning'
'Compulsory licence verdict doesn't violate multilateral trade agreement'

Big Pharma vs India - Round 3: Roche's Hepatitis C drug Pegasys' patent revoked

Judges tell Novartis at Rs 1.2 lakh a month, drugs too expensive for them!
Novartis claims to have distributed free drugs worth Rs 7,500 cr

India vs Big Pharma: Compulsory licence for leukaemia drug sought

Top health newsmakers of 2012

Latest Ebola News: Big pharma to blame for lack of Ebola vaccine?
Novartis AG loses patent battle, cancer drugs to be cheaper

Indian pharma to reach new heights but will it be able to maintain quality?

Global Big Pharma targeting Indian pharmaceutical industry?

A hard-hitting movie about the triumph of good over evil.
India vs Big Pharma: Roche's breast cancer drug Hereceptin loses patent

Ranbaxy's Indian facilities under scanner: Ghulam Nabi Azad

'Compulsory licence verdict a triumph for humanity'

Experts believe that this case will set a precedent for all future legal tangles between Big Pharma and the country as a marker of how cases pertaining to drug patents will be played out in the country.
Ranbaxy ordered to shell out 420,000 dollars as settlement to settle criminal complaints
Ranbaxy goes on mass retrenching spree: Set to fire 400 employees in the next few months
Supreme Court dismisses PIL against Ranbaxy Laboratories
Now consent for clinical trials to be recorded on camera
Ranbaxy to pay $500 mn to settle US fraud charges
What Monica Lewinsky and Indian generic drugs have in common – Bill Clinton loves them both
Now government hospitals in Maharashtra to use generic drugs
Novartis not optimistic about Supreme Court verdict
Leading lawyer calls India's pharma sector 'hip and hapenning'
'Compulsory licence verdict doesn't violate multilateral trade agreement'

Big Pharma vs India - Round 3: Roche's Hepatitis C drug Pegasys' patent revoked

Judges tell Novartis at Rs 1.2 lakh a month, drugs too expensive for them!
Novartis claims to have distributed free drugs worth Rs 7,500 cr